Welcome to the Homepage of

PACT – Platform for Advanced Cellular Therapies



PACT Summer School 2022

New aspects in cell-based therapies –

From basic science to treatment of patients”

04 – 08 July 2022 in Vienna


The aim of the PACT Summer School is to provide a new generation of stem cell researchers with the holistic perspective needed to successfully work in emerging and divergent areas of various medical research fields and illustrate their potential applications in clinical scenarios.


Top-notch scientists have put together a challenging program:  In addition to outstanding lectures on current clinical and experimental strategies for treating humans and animals with cell-based therapies and on methods for characterizing and measuring the tissue being processed, they also demonstrated the relevant methods and techniques in the lab and guided participants to try everything out for themselves.


In addition, the school program included an entrepreneurship session and guided tours at the University of Veterinary Medicine Vienna as well as at the Clinic for Transfusion Medicine and Blood Group Serology and the Stem Cell Transplantation Unit at the University Hospital Vienna.


All this made the program an exceptional example of perfect knowledge transfer, covering a broad spectrum from basic research to clinical background and practical skills in the laboratory.


10 enthusiastic participants proved to be hard workers and always followed the lectures and instructions in the lab with dedication. Although the program was quite intense and demanding, everyone remained attentive until the end of the week and actively participated in the discussions during the lectures and practical exercises.


Despite this dense schedule, the curriculum left plenty of time for discussion and networking during and between sessions and at social events: We had a wonderful dinner at a restaurant on the Alte Donau and a party each at the end of our first and last day with cocktails, canapes and cake!


We would like to thank the teaching team and all the participants for making this week such a special event!


Here are some of the many positive responses:


“Nice structure and good atmosphere in the lab”
“Really good & very well organized, especially enjoyed working with the placenta”
“Thank you for the perfect thoughtthrough organisation, high quality summer school (but specific)”
“Great experience, very detailed”
“I really enjoyed the program”
“Thank you for having us!”


Recap EACTS – PACT Joint Symposium

„Regenerative Medicine: Taking the Science to the Patient“

30th November and 1st December 2017

Vienna, Austria


By the time you read this, we trust that you have returned safe and well to your work place with a motivation and determination to continue your work at least a little, in some aspect, inspired by our joint symposium.


The aim of scientific work in the field of regenerative medicine is to develop devices or novel cell based therapies and derived products that will serve to treat or cure disease-ridden patients. Indeed, to augment and exchange knowledge between groundbreaking fundamental research, the “clinic” and the health agencies that finally approve novel medical devices and novel drug therapies to society. With this in mind, EACTS and PACT joined forces to organize a meeting that brought together basic scientist, clinicians, regulatory affairs and service providers to discuss outlook and progress in regenerative medicine.


Especially in the cardiothoracic field which was the focus of this year’s symposium the “cell centric vision” is under heavy discussion after potential cell based therapies in myocardial infarction have not lived up to the expectations hypothesized by preclinical research. However, novel scientific developments like secretory products derived from cells with regenerative and/or cytoprotective capabilities can now be seen on the horizon of scientific endeavour.


At the Symposium, the excellent quality of the chairs, their session keynotes and speakers with your enthusiasm as participants contributed greatly to make this symposium not only successful but an exhilarating experience. At this point, we would like to thank our Sponsors again very much indeed, since without their support and loyalty such a Symposium would simply not occur. It was also very gratifying to note that so much of the “audience” was students to whom the future of our knowledge belongs and who can continue to develop their skills for patient benefit.


Undoubtedly, cell based therapies will come to the benefit of patients or indeed, cell derived “soups” will develop into “cocktails” or regimes for treatments that will contribute to relieve human and animal disease or suffering.


Finally, we would like to draw your attention to the Book of Abstracts that is available now and the Video Recordings of highlights of this Symposium that will be available by end of January 2018.


“What appears as the impossible is more likely to happen the more often it is attempted” let us continue to work together in “Taking the Science to the Patient”.


Michael Comer, Hendrik Jan Ankersmit, Beatrix Mayer-Reinprecht


We cordially welcome our new Institute Member

Center for Translational Medicine (CTM)

International Clinical Research Center 

St. Anne’s University Hospital Brno


St. Anne’s University Hospital Brno
International Clinical Research Center
Pekařská 53
656 91 Brno
Czech Republic



The Center for Translational Medicine (CTM) is a highly interdisciplinary research platform in the International Clinical Research Center (FNUSA-ICRC), a European Union-funded project of the St. Anne’s University Hospital Brno (Czech Republic). The funds so far collected from EU were mostly used to build its own state-of-the-art translational medical research premises. The research center, currently hosts young promising researchers and students from all over the world (9 nationalities represented) and aims at unveiling the molecular mechanisms involved in the onset and progression of the diseases of aging. For this purpose, CTM adopts original and interdisciplinary approaches based on the use of smart materials, microfluidics systems, bioreactors, mechanically-assisted devices and multi-faceted molecular and cellular biology skills to investigate the molecular basis of complex diseases.  more


Stem Cells‬ for Age-related Macular Degeneration

Nature News: Japanese woman is first recipient of next-generation stem cells. Surgeons implanted retinal tissue created after reverting the patient’s own cells to ‚pluripotent‘ state.